Alector LLC

Alector is a clinical-stage biotechnology company that focuses on developing immuno-neurology therapies for neurodegenerative diseases. They are committed to pioneering a new approach to treating Alzheimer's disease, frontotemporal dementia, and other forms of dementia. With a unique understanding of the immune system's role in neurodegenerative disorders, Alector aims to harness the power of the immune system to slow down or halt the progression of these diseases. Through their innovative research and collaboration with academic institutions, they strive to make a lasting impact on patients' lives.